Positive Rett trials also means a Japanese ph2/3 Rett trial commencement. Dont we need a Japanese partner to run a trial in Japan? I thought this was the case... if true, I’m thinking we will have a partner from Japan by end of 2021 as well.
If you have looked at what Laderburg has said and written in arriving at their target price, they have conspicuously ignored AD in favor of only Rett -- even though they project earnings for 2022 and 2023. I think they will update with AD projections once full enrollment is announced.
Did you invest here for Rett or Alz? I certainly didnt for Rett as I can get a home-run elsewhere with much less risk. I want a grand-slam which is Alz, and I am sure I am not the only one, in fact I am certain. The fact is Alz is looking more successful with each trial completion as we learn more about 2-73 and many investors including myself are willing to take the risk as we get more data and info from placebo trials. To say Alz has little bearing on current and immediate future SP is like saying Tesla's future (1-3 year timeframe) battery technology and future EV's has nothing to with Tesla's current valuation.